Kairos Pharma, LTD.
KAPA· NYSE
Kairos Pharma, LTD.
- Last sale
- Oct 2, 2026 · -1.89%
- Market cap
- $36.97M
- 23.7M shares
- Filings
- 122
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,135,000 | reported | |
| FY 2024 | 2024-12-31 | $414,000 | reported | |
| FY 2023 | 2023-12-31 | $82,000 | reported |
Kairos Pharma, LTD. · CIK 1962011 · Engraved from SEC EDGAR
